Advanced Enzyme Technologies Q2 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
343.7
3.50 (1.03%)
3.50 (1.03%)Volume5.55 K
Updated: Thu 16 Jan, 2025 | 15:02:20
NSE
344.24.65 (1.37%)
4.65 (1.37%)Volume59.82 K
Updated: Thu 16 Jan, 2025 | 14:49:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹146.09 Cr.(-7.44%)
- Operating Profit₹33.52 Cr.(-21.29%)
- Profit After Tax₹32.83 Cr.(-4.58%)
- Operating Margin22.94%(-14.96%)
Note: Comparison is on YoY basis
Quarterly - Advanced Enzyme Technologies Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 24 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 146.09 | 154.52 | -5.45% | 157.84 | -7.44% |
| Selling/ General/ Admin Expenses Total | 35.52 | 34.66 | 2.49% | 31.68 | 12.12% |
| Depreciation/ Amortization | 8.89 | 8.61 | 3.27% | 8.73 | 1.93% |
| Other Operating Expenses Total | 35.46 | 34.45 | 2.92% | 37.84 | -6.30% |
| Total Operating Expense | 112.58 | 111.97 | 0.54% | 115.26 | -2.33% |
| Operating Income | 33.52 | 42.55 | -21.23% | 42.59 | -21.29% |
| Net Income Before Taxes | 42.21 | 48.67 | -13.28% | 47.93 | -11.93% |
| Net Income | 32.83 | 34.15 | -3.86% | 34.41 | -4.58% |
| Diluted Normalized EPS | 2.93 | 3.05 | -3.93% | 3.08 | -4.87% |